Healthcare
MeiraGTx Holdings plc
MGTXPrice is delayed.
About MeiraGTx Holdings plc
MeiraGTx is a biotechnology company developing genetic medicines, which are treatments that work by delivering healthy genes into a patient's body to fix genetic diseases. The company is testing experimental therapies for inherited eye diseases, Parkinson's disease, dry mouth conditions, and other serious genetic disorders. Most of their treatments use a technology called AAV, a modified virus that carries genetic instructions into cells. The company has partnerships with Johnson & Johnson and other organizations to research and develop these gene therapies.
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore